[Federal Register Volume 77, Number 103 (Tuesday, May 29, 2012)]
[Notices]
[Pages 31624-31625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12864]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: June 19, 2012.
    Time: 9:00 a.m. to 3:30 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
discuss selected human gene transfer protocols. Please view the 
meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html 
for more information.
    Place: National Institutes of Health, Building 31C, 9000 
Rockville Pike, 6th Floor Conference Room, Rockville, MD 20892.
    Contact Person: Chezelle George, Office of Biotechnology 
Activities, Office of Science Policy/OD, National Institutes of 
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, [email protected].
    OBA will again offer those members of the public viewing the 
meeting via webcast (see OBA Meetings Page available at http://oba.od.nih.gov/rdna_rac/rac_meetings.html) the opportunity to 
submit comments during the public comment periods. Individuals 
wishing to submit comments should use the comment form, which will 
accommodate comments up to 1500 characters, and will be available on 
the OBA Web site during the meeting (see OBA Meetings Page). Please 
limit your comments to a statement that can be read in one to two 
minutes. Please include your name and affiliation with your comment. 
Only comments submitted through the OBA Web site will be read.
    OBA will read comments into the record during the public comment 
periods as stated on the agenda. It is not unusual for the meeting 
to run ahead or behind schedule due to changes in the time needed to 
review a protocol. It is advisable to monitor the webcast to 
determine when public comments will be read. Each public comment 
period follows a specific discussion item. OBA will

[[Page 31625]]

read comments that are related to the protocol under discussion at 
that time. General comments unrelated to the protocol or 
presentation under discussion at that time. General comments 
unrelated to a specific agenda item will be read at the end of the 
meeting, time permitting. Comments submitted by email through the 
OBA Web site will follow any comments by individuals attending the 
meeting. Comments will be read in the order received and your name 
and affiliation will be read with the comments. Please note OBA may 
not be able to read every comment received in the time allotted for 
public comment. Comments not read will become part of the public 
record.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit. Information is also available on the Institute's/Center's 
home page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and 
any additional information for the meeting will be posted when 
available.

    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-12864 Filed 5-25-12; 8:45 am]
BILLING CODE 4140-01-P